Cargando…

223. Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs

BACKGROUND: Desirability of outcome ranking (DOOR) uses an ordinal ranking system to evaluate global outcomes in clinical trial participants by incorporating safety and efficacy assessments into a single endpoint. In this study, we developed and applied a DOOR endpoint for cIAI clinical trials. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinamon, Tori, Gopinath, Ramya, Waack, Ursula, Needles, Mark, Rubin, Daniel, Collyar, Deborah, Doernberg, Sarah B, Evans, Scott R, Hamasaki, Toshimitsu, Holland, Thomas L, Howard-Anderson, Jessica, Chambers, Henry, Fowler, Vance G, Nambiar, Sumathi, Kim, Peter, Boucher, Helen W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752299/ http://dx.doi.org/10.1093/ofid/ofac492.301

Ejemplares similares

2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)
por: Aronin, Steven I, et al.
Publicado: (2023)

492 Complicated Intra-abdominal Infection (cIAI) and 30-day Hospital Readmission
por: Furuno, Jon P., et al.
Publicado: (2014)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
por: Ferrer, Ricard, et al.
Publicado: (2021)

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
por: Kongnakorn, Thitima, et al.
Publicado: (2019)

An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by Enterobacterales in Critically Ill Adult Patients
por: Gatti, Milo, et al.
Publicado: (2021)

IAI NUPECC
Publicado: (2001)

2264. An Evaluation of Empiric Treatment Patterns for Adult Patients with Community-Onset (CO) “Low-Risk” (LR) Complicated Intra-Abdominal Infections (cIAI) Across US Hospitals
por: Lodise, Thomas, et al.
Publicado: (2019)

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
por: Solomkin, Joseph, et al.
Publicado: (2015)

2035. Clinical and Economic Outcomes in Patients with Complicated Urinary Tract Infection (cUTI) and Complicated Intra-Abdominal Infection (cIAI) in Perú: Impact of Gram-Negative Organisms (GNO) Resistant to Antibiotics
por: Hercilla, Luis, et al.
Publicado: (2019)

Host Immune Regulation in Implant-Associated Infection (IAI): What Does the Current Evidence Provide Us to Prevent or Treat IAI?
por: Maimaiti, Zulipikaer, et al.
Publicado: (2023)

Sample size determination in clinical trials with multiple endpoints
por: Sozu, Takashi, et al.
Publicado: (2015)

369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
por: Hamasaki, Toshimitsu, et al.
Publicado: (2023)

189. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
por: Dagher, Michael M, et al.
Publicado: (2020)

Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints
por: Huang, Wong-Shian, et al.
Publicado: (2017)

Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)
por: Sugimoto, Tomoyuki, et al.
Publicado: (2016)

IAIS Symposium on Novel Molecular Approaches to Anti-inflammatory Therapy 22–23 July 1994 Toronto Canada
Publicado: (1994)

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
por: Hamada, Katsuyuki, et al.
Publicado: (2014)

An alternative analgesic agent for intra-articular corticosteroid injections (IAI) in juvenile idiopathic arthritis (JIA) – a fentanyl lollipop
por: Zareen, Z, et al.
Publicado: (2011)

Intra-abdominal infection (IAI) following cesarean section: a retrospective study in a tertiary referral hospital in Egypt
por: Abdelraheim, Ahmed R., et al.
Publicado: (2019)

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
por: Howard-Anderson, Jessica, et al.
Publicado: (2022)

Tracking Demographic Movements and Immunization Status to Improve Children's Access to Immunization (TDM-IAI): Protocol for a Field-Based Randomized Controlled Trial
por: Ateudjieu, Jérôme, et al.
Publicado: (2021)

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
por: Turner, Nicholas A., et al.
Publicado: (2022)

Reply: From the “Door-to-Antibiotic” to the “Antibiotic-at-Door” Concept?
por: Peltan, Ithan D., et al.
Publicado: (2019)

412 In vitro Activity of Key Antimicrobial Agents Against Bacterial Isolates From Intra-abdominal (IAI) and Skin and Wound (SW) Infections: Europe 2004-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

The open door /
por: Howard, Blanche Willis, 1847-1898
Publicado: (1889)

Hospital Doors
Publicado: (1911)

The Closed Door
Publicado: (1905)

Doors of Hope
Publicado: (1935)

Shut the Door
Publicado: (1874)

Death In-Doors
Publicado: (1866)

Death In-doors
Publicado: (1876)

In-Door Amusement
Publicado: (1872)

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan
por: Khan, Suliman, et al.
Publicado: (2016)

Essential Surgical Technique for French-Door (Double-Door) Laminoplasty
por: Nakashima, Hiroaki, et al.
Publicado: (2015)

Pharmacovigilance Symposium ISCR Annual Conference Jan 5, 2013: Safety aspects of hard endpoint or outcome trials
por: Suvarna, Viraj, et al.
Publicado: (2013)

The encyclopedia of doors : puertas.
Publicado: (2002)

Door-to-door canvassing as a means of family planning patient recruitment.
por: Cates, W., et al.
Publicado: (1969)

Burden of migraine in a Kuwaiti population: a door-to-door survey
por: Al-Hashel, Jasem Yousef, et al.
Publicado: (2017)

Opening doors : idioms in English /
por: Zucaro, Michael A.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_9n3mjjhq4n3fu44e87uik1lu4e